Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Product Information
-
DIN:02511932
-
Active Ingredients :Bortezomib
-
Innovator Name:Velcade®
-
Category:Antineoplastic Agent
-
Dosage form:Sterile lyophilized powder
-
Strength:2.5 mg
-
Route of Administration:Intravenous or subcutaneous
- Package size:
2.5 mg per vial - UPC Code:
063691100633 -
Description :Taro-Bortezomib (bortezomib) for Injection is supplied in individually cartoned 10 mL vials containing 2.5 mg or 3.5 mg of bortezomib as a mannitol boronic ester, as a white to off-white cake or powder.
-
Non-medicinal ingredients :Mannitol
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02499061
-
Active Ingredients :Bortezomib
-
Innovator Name:Velcade®
-
Category:Antineoplastic Agent
-
Dosage form:Sterile lyophilized powder
-
Strength:3.5 mg
-
Route of Administration:Intravenous or subcutaneous
- Package size:
3.5 mg per vial - UPC Code:
063691088979 -
Description :Taro-Bortezomib (bortezomib) for Injection is supplied in individually cartoned 10 mL vials containing 3.5 mg of bortezomib as a mannitol boronic ester, as a white to off-white cake or powder.
-
Non-medicinal ingredients :Mannitol
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here